Market Research Report
Global Needle Free Drug Delivery Devices Market Research and Analysis 2015-2022
|Published by||Orion Market Research Pvt Ltd||Product code||505711|
Delivery time: 1-2 business days
|Global Needle Free Drug Delivery Devices Market Research and Analysis 2015-2022|
|Published: May 19, 2017||Content info:||
The Global needle free drug delivery devices Market is expected to grow at a modest CAGR of 16.7% during 2017-2022. The Needle free drug delivery technology is a most innovative technique to deliver drugs into a person's body without piercing their skin. The market is growing at a very fast majorly due to rising geriatric population, technological advancement and so on. The rising need for self-administration of drugs as in the case of diseases like diabetes and pain-free drug delivery have consequentially enhanced the industry share of global needle-free drug delivery devices. Furthermore, controlled dosing ability, rapid drug administration and minimal damage to skin are the key associated benefits boosting the physician preference thereby fueling the demand for the global market. Additionally, the increasing focus on the growth of portable delivery devices has a positive, high impact on the needle-free drug delivery devices market globally. These aforesaid advantages related to needle-free drug delivery devices are anticipated to serve as key boasting factors spurring the growth of the global needle-free drug delivery devices market over the forecast period.
On the other hand, low awareness regarding needle free technology and high development cost of needle-free injection systems over the conventional needle injection may act as a roadblock in the growth of this market during the forecast period. The report includes detailed Market Overview, Analyst Insights and predictive analysis, Market Determinants, Market Segmentation, Geographical Analysis, Strategic Recommendations, Key Company Analysis, Key Findings, Market Insights and Company Profiling.
Global needle free drug delivery devices Market is regionally segmented into North America, Europe, Asia Pacific and Rest of the world. North American region dominates the global market, this region held the largest revenue share of the global Needle Free drug delivery devices market in 2016. This can be attributed majorly due to the increasing prevalence of chronic diseases, , high awareness pertaining to novel drug delivery systems among the patient base, development of biologics and pharmaceutical drugs and devices and an increasing number of R&D investments by prominent market players domiciled in this region.
The Asia Pacific region is anticipated to witness lucrative growth opportunities in the upcoming future, growing at a CAGR of approx. 16.0% during the forecast period. This is a consequence of the increasing elderly population requiring home-based, Needle Free drug delivery devices for enhanced mobility, and the rising healthcare disbursement in emerging economies such as India and China.
The Key Players In The Global needle free drug delivery devices Market Include 3 M, AkraDermojetInc, Antares Pharma Inc., Bayer Ag, Bioject Medical Technologies, Inc., GlaxosmithklinPlc, Glide Pharmaceutical Technologies Ltd., InjexPharma Ag, Jdrf, Johnson & Johnson, Inc., Medtronic, Inc., Merck And Co., Nemera, Novartis Ag, PancreumLlc, Pfizer, Inc., Pharmajet, Inc., Sanofi, Tandem Diabetes Care, Inc., Zogenix, Inc. And so on Partnership, R&D, M&A, Product Launch Are the Key Strategy Adopted In The global needle free drug delivery devices Market.
Global needle free drug delivery devices Market is segmented on the basis of technology, applications, end users and regional outlook. On the basis of technology market is divided into Oral drug delivery system, Inhaler technology, Laser based needle free injectors, Jet injectors, Novel needle free technologies, spring based needle free injectors, Transdermal patch technology and other needle free technology. The Jet injectors is having the largest market share and is dominating the technology segment in 2016, majorly due to its high usage rate and extensive applicability in delivering a large range of drugs.